Vicore initiates clinical proof-of-concept study of endothelial dysfunction
Drug Discovery World
MAY 3, 2023
The study Vicore is conducting a randomised, double-blind, placebo-controlled, cross-over trial evaluating the effect of ATRAGs on endothelial dysfunction (reflecting blood vessel health) in patients with type-2-diabetes-mellitus (T2DM )1, a condition where endothelial dysfunction is central in the development of organ damage. The trial will (..)
Let's personalize your content